Clinical Trials Directory

Trials / Conditions / Focal Onset Seizures

Focal Onset Seizures

10 registered clinical trials studyying Focal Onset Seizures — 3 currently recruiting.

StatusTrialSponsorPhase
RecruitingSPN-817 Open-Label Extension Study in Adults With Focal Onset Seizures
NCT07141329
Supernus Pharmaceuticals, Inc.Phase 2
RecruitingRENAISSANCE 2: SPN-817 Phase 2, Double-Blind, Placebo-Controlled Study in Adults with Focal Onset Seizures
NCT06798896
Supernus Pharmaceuticals, Inc.Phase 2
CompletedStudy Evaluating the Safety and Efficacy of RAP-219 in Adult Participants With Refractory Focal Epilepsy
NCT06377930
Rapport Therapeutics Inc.Phase 2
RecruitingA Randomized Study of XEN1101 Versus Placebo in Focal-Onset Seizures (X-TOLE3)
NCT05716100
Xenon Pharmaceuticals Inc.Phase 3
TerminatedStudy of EQU-001 for Uncontrolled Focal Onset Seizures
NCT05473442
Equilibre Biopharmaceuticals B.V.Phase 2
CompletedA Randomized Study of XEN1101 Versus Placebo in Focal-Onset Seizures
NCT05614063
Xenon Pharmaceuticals Inc.Phase 3
CompletedA Study to Investigate JNJ-40411813 in Combination With Levetiracetam or Brivaracetam in Epilepsy
NCT04836559
Janssen Research & Development, LLCPhase 2
TerminatedA Study to Test the Efficacy and Safety of Padsevonil as Treatment of Focal-onset Seizures in Adult Subjects W
NCT03739840
UCB Biopharma SRLPhase 3
TerminatedStudy to Test the Safety and Efficacy of Padsevonil as Adjunctive Treatment of Focal-onset Seizures in Adult S
NCT03370120
UCB Biopharma SRLPhase 2
CompletedStudy to Test the Efficacy and Safety of Padsevonil as Adjunctive Treatment of Focal-onset Seizures in Adults
NCT03373383
UCB Biopharma S.P.R.L.Phase 2